• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.

作者信息

Chaudhuri Aadel A, Pellini Bruna, Pejovic Nadja, Chauhan Pradeep S, Harris Peter K, Szymanski Jeffrey J, Smith Zachary L, Arora Vivek K

机构信息

Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO.

Department of Genetics, Washington University School of Medicine, St Louis, MO.

出版信息

JCO Precis Oncol. 2020 Jul 15;4. doi: 10.1200/PO.20.00060. eCollection 2020.

DOI:10.1200/PO.20.00060
PMID:32923907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7448529/
Abstract
摘要

相似文献

1
Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.基于尿液的肿瘤DNA分析在膀胱癌管理中的新兴作用
JCO Precis Oncol. 2020 Jul 15;4. doi: 10.1200/PO.20.00060. eCollection 2020.
2
Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer.基于大小对尿液中脱落肿瘤细胞进行富集可提高基于DNA检测膀胱癌的灵敏度。
PLoS One. 2014 Apr 14;9(4):e94023. doi: 10.1371/journal.pone.0094023. eCollection 2014.
3
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.当前和新兴的膀胱癌生物标志物，重点是尿液生物标志物。
Expert Rev Mol Diagn. 2020 Feb;20(2):231-243. doi: 10.1080/14737159.2020.1699791. Epub 2019 Dec 11.
4
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.根治性膀胱切除术治疗肌层浸润性膀胱癌患者微小残留病灶的尿液肿瘤 DNA 检测：一项队列研究。
PLoS Med. 2021 Aug 31;18(8):e1003732. doi: 10.1371/journal.pmed.1003732. eCollection 2021 Aug.
5
Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.通过肿瘤抑制基因高甲基化检测板检测尿液中的膀胱癌
Clin Cancer Res. 2004 Mar 15;10(6):1887-93. doi: 10.1158/1078-0432.ccr-03-0127.
6
Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes.通过选定肿瘤抑制基因的高甲基化检测面板检测尿沉渣中的膀胱癌
Cancer Biomark. 2017;18(1):47-59. doi: 10.3233/CBM-160673.
7
A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.在肉眼血尿患者中检测尿 DNA 以检测尿路上皮膀胱癌的前瞻性盲法评估。
Eur Urol. 2016 Dec;70(6):916-919. doi: 10.1016/j.eururo.2016.06.035. Epub 2016 Jul 11.
8
Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.用于检测膀胱癌的肿瘤和尿液DNA缺失分析：尿液上清液与尿液沉淀物的比较
Oncol Rep. 2007 Aug;18(2):405-9.
9
The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion.泌尿生殖系统癌症患者尿液中肿瘤DNA的起源：局部脱落和经肾排泄。
Cancers (Basel). 2021 Jan 31;13(3):535. doi: 10.3390/cancers13030535.
10
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.膀胱癌患者尿沉渣中甲基化凋亡相关基因的检测
Clin Cancer Res. 2004 Nov 15;10(22):7457-65. doi: 10.1158/1078-0432.CCR-04-0930.

引用本文的文献

1
Liquid Biopsy: Current advancements in clinical practice for bladder cancer.液体活检：膀胱癌临床实践的当前进展
J Liq Biopsy. 2025 Jul 8;9:100310. doi: 10.1016/j.jlb.2025.100310. eCollection 2025 Sep.
2
Bladder sparing management for muscle-invasive bladder cancer after a complete clinical response: ready for prime time?-a narrative review.完全临床缓解后肌肉浸润性膀胱癌的保膀胱治疗：准备好成为主流了吗？——一篇叙述性综述
Transl Cancer Res. 2024 Nov 30;13(11):6413-6429. doi: 10.21037/tcr-24-726. Epub 2024 Nov 11.
3
A Novel Urine DNA Predictor for Noninvasive Early Diagnosis and Monitoring Minimal Residual Disease of Upper Tract Urothelial Carcinoma.一种新型尿液 DNA 预测因子，用于非侵入性早期诊断和监测上尿路上皮癌的微小残留病灶。
Cancer Med. 2024 Oct;13(20):e70346. doi: 10.1002/cam4.70346.
4
Enhancing PDT efficacy in NMIBC: Efflux inhibitor mediated improvement of PpIX levels and efficacy of the combination of PpIX-PDT and SO-cleavable prodrugs.提高非肌层浸润性膀胱癌 PDT 疗效：外排泵抑制剂介导的原卟啉 IX 水平提高和原卟啉 IX-PDT 与 SO 可切割前药联合应用的疗效改善。
Photochem Photobiol. 2024 Nov-Dec;100(6):1636-1646. doi: 10.1111/php.13982. Epub 2024 Jun 12.
5
From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.从检测到治疗——尿液肿瘤 DNA（utDNA）在膀胱癌中的新兴作用。
Curr Oncol Rep. 2024 Aug;26(8):945-958. doi: 10.1007/s11912-024-01555-0. Epub 2024 Jun 5.
6
Unlocking the potential of tumor-derived DNA in urine for cancer detection: methodological challenges and opportunities.挖掘尿液中肿瘤衍生DNA在癌症检测中的潜力：方法学挑战与机遇
Mol Oncol. 2024 Mar 10. doi: 10.1002/1878-0261.13628.
7
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA.利用循环肿瘤 DNA 进行癌症和微小残留病灶检测的基因组方法。
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2022-006284.
8
Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA.通过尿液DNA靶向深度测序准确检测尿路上皮膀胱癌
Cancers (Basel). 2023 May 22;15(10):2868. doi: 10.3390/cancers15102868.
9
Non-Invasive Imaging Modalities in Intravesical Murine Models of Bladder Cancer.膀胱癌膀胱内小鼠模型中的非侵入性成像模态
Cancers (Basel). 2023 Apr 20;15(8):2381. doi: 10.3390/cancers15082381.
10
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.根治性膀胱切除术治疗肌层浸润性膀胱癌患者微小残留病灶的尿液肿瘤 DNA 检测：一项队列研究。
PLoS Med. 2021 Aug 31;18(8):e1003732. doi: 10.1371/journal.pmed.1003732. eCollection 2021 Aug.

本文引用的文献

1
Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.基于尿液游离 DNA 浅全基因组测序的拷贝数图谱的尿路上皮癌检测。
Clin Chem. 2020 Jan 1;66(1):188-198. doi: 10.1373/clinchem.2019.309633.
2
Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.局部食管癌放化疗后循环肿瘤 DNA 分析检测微小残留病灶。
Gastroenterology. 2020 Feb;158(3):494-505.e6. doi: 10.1053/j.gastro.2019.10.039. Epub 2019 Nov 9.
3
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.厄达替尼治疗局部晚期或转移性尿路上皮癌。
N Engl J Med. 2019 Jul 25;381(4):338-348. doi: 10.1056/NEJMoa1817323.
4
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).利用循环肿瘤 DNA（ctDNA）检测实体瘤分子残留疾病（MRD）。
Mol Diagn Ther. 2019 Jun;23(3):311-331. doi: 10.1007/s40291-019-00390-5.
5
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.对 472 例不同分级和解剖部位的尿路上皮癌的突变分析。
Clin Cancer Res. 2019 Apr 15;25(8):2458-2470. doi: 10.1158/1078-0432.CCR-18-3147. Epub 2018 Dec 28.
7
Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma.用于尿路上皮癌诊断和监测的新兴生物标志物。
Res Rep Urol. 2018 Dec 14;10:251-261. doi: 10.2147/RRU.S173027. eCollection 2018.
8
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.使用尿液肿瘤 DNA 检测和监测膀胱癌。
Cancer Discov. 2019 Apr;9(4):500-509. doi: 10.1158/2159-8290.CD-18-0825. Epub 2018 Dec 21.
9
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.评估尿游离DNA和沉淀物DNA中TERT启动子突变用于检测膀胱癌
Clin Biochem. 2019 Feb;64:60-63. doi: 10.1016/j.clinbiochem.2018.11.009. Epub 2018 Dec 4.
10
Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer.Xpert 膀胱癌监测仪在非肌肉浸润性膀胱癌患者随访中的诊断预测价值。
J Clin Pathol. 2019 Feb;72(2):140-144. doi: 10.1136/jclinpath-2018-205393. Epub 2018 Oct 24.